Engineering broadly neutralizing antibodies for HIV prevention and therapy.
about
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodiesBispecific antibodies for viral immunotherapy.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.Anti-HIV Passive Immunization: New Weapons in the Arsenal.The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs
P2860
Engineering broadly neutralizing antibodies for HIV prevention and therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Engineering broadly neutralizing antibodies for HIV prevention and therapy.
@en
type
label
Engineering broadly neutralizing antibodies for HIV prevention and therapy.
@en
prefLabel
Engineering broadly neutralizing antibodies for HIV prevention and therapy.
@en
P2860
P1476
Engineering broadly neutralizing antibodies for HIV prevention and therapy.
@en
P2093
Casey K Hua
Margaret E Ackerman
P2860
P304
P356
10.1016/J.ADDR.2016.01.013
P407
P577
2016-01-28T00:00:00Z